CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The main objective of this study is to evaluate the efficacy of venetoclax in combination with azacitidine to improve Overall Survival (OS) in Acute...
Phase 3
Orlando, Florida, United States and 164 other locations
to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...
Phase 2
Orlando, Florida, United States and 56 other locations
[GO]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse who...
Phase 3
Orlando, Florida, United States and 71 other locations
This study enrolled 472 participants, aged 55 or older, with a diagnosis of de novo acute myeloid leukemia (AML) ...
Phase 3
Orlando, Florida, United States and 222 other locations
three separate safety run-in cohorts in neuroblastoma, acute myeloid leukemia (AML), and acute lymphobla...
Phase 1, Phase 2
Orlando, Florida, United States and 19 other locations
which contains populations of CD8+ T cells targeting multiple leukemia associated antigen peptides in patients with Acute Myeloid...
Phase 1, Phase 2
Orlando, Florida, United States and 4 other locations
This study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart...
Phase 1
Lake Mary, Florida, United States and 57 other locations
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior in...
Phase 3
Orlando, Florida, United States and 38 other locations
azacitidine. (An event is defined as death or transformation to AML in participants with MDS or CMML, whichever occurs first, and is defined...
Phase 3
Orlando, Florida, United States and 240 other locations
Clinical trials
Research sites
Resources
Legal